ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Fallout Study On Split Vote

March 13, 1981

New NIH Program To Develop Therapies For Rare, Neglected Diseases

June 19, 2009

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

In Brief: House Members Not Told They were Voting Anti-Impoundment Feature Into Cancer Bill

July 19, 1974

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991